290 related articles for article (PubMed ID: 14503930)
1. Using insulin as a drug rather than as a replacement hormone during acute illness: a new paradigm.
Pantaleo A; Zonszein J
Heart Dis; 2003; 5(5):323-33. PubMed ID: 14503930
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
[TBL] [Abstract][Full Text] [Related]
3. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
Nathanson D; Nyström T
Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
[TBL] [Abstract][Full Text] [Related]
5. From hyperglycemia to the risk of cardiovascular disease.
Leiter LA
Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes.
Dandona P; Chaudhuri A; Ghanim H; Mohanty P
Rev Cardiovasc Med; 2006; 7 Suppl 2():S25-34. PubMed ID: 17224874
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
8. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Leiter LA; Lewanczuk RZ
Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
[TBL] [Abstract][Full Text] [Related]
9. Insulin strategies for managing inpatient and outpatient hyperglycemia and diabetes.
Moghissi ES
Mt Sinai J Med; 2008 Dec; 75(6):558-66. PubMed ID: 19021195
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
Rosenberg DE; Jabbour SA; Goldstein BJ
Diabetes Obes Metab; 2005 Nov; 7(6):642-53. PubMed ID: 16219008
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of newly diagnosed diabetes in clinical settings.
Nesto RW
Rev Cardiovasc Med; 2006; 7 Suppl 2():S18-24. PubMed ID: 17224873
[TBL] [Abstract][Full Text] [Related]
12. Management of diabetes in the hospital.
Fonseca V
Rev Cardiovasc Med; 2006; 7 Suppl 2():S10-7. PubMed ID: 17224872
[TBL] [Abstract][Full Text] [Related]
13. PPAR agonists and the metabolic syndrome.
Staels B
Therapie; 2007; 62(4):319-26. PubMed ID: 17983557
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia contributes to cardiac dysfunction in a lipopolysaccharide-induced systemic inflammation model.
Hagiwara S; Iwasaka H; Hasegawa A; Asai N; Noguchi T
Crit Care Med; 2009 Jul; 37(7):2223-7. PubMed ID: 19487929
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
Ahmed I; Goldstein BJ
Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle modification and endothelial function in obese subjects.
Hamdy O
Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
[TBL] [Abstract][Full Text] [Related]
17. Association of hyperglycemia and insulin with diabetic cardiovascular complications.
Khamaisi M; Wainstein J; Hancu N; Milicevic Z; Raz I
Isr Med Assoc J; 2003 Feb; 5(2):116-9. PubMed ID: 12674662
[TBL] [Abstract][Full Text] [Related]
18. Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
Yamagishi S; Matsui T; Sato T; Takeuchi M
Med Hypotheses; 2006; 66(3):609-11. PubMed ID: 16171951
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.
Rana JS; Nieuwdorp M; Jukema JW; Kastelein JJ
Diabetes Obes Metab; 2007 May; 9(3):218-32. PubMed ID: 17391148
[TBL] [Abstract][Full Text] [Related]
20. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors.
Reasner CA
J Cardiovasc Pharmacol; 2008 Aug; 52(2):136-44. PubMed ID: 18670366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
